Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/91425
| Title: | Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia : comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice | Authors: | Chan, CW Molassiotis, A Lee, HKK |
Issue Date: | Dec-2021 | Source: | Supportive care in cancer, Dec. 2021, v. 29, no. 12, p. 7515-7523 | Abstract: | Purpose: The efficacy of prophylactic antimicrobial treatment renders challenges in patients with leukemias receiving chemotherapy. The study aimed to compare differences in C-reactive protein (CRP) and procalcitonin (PCT) at presentation and the immediate outcome measures of post-chemotherapy NF between patients with and without antimicrobial prophylaxis. Methods: A 5-year observational study included 282 NF episodes in 133 leukemia patients requiring hospital care from January 2014 to May 2019. We collected demographic characteristics, laboratory data of blood cell counts and inflammatory biomarkers, and immediate outcome measures of NF, including microbiologically diagnosed infections, presence of predominant pathogens, required modification of antibiotics during NF, adverse medical complications, total fever duration, and deaths. We evaluated data between patients with and without prophylaxis. Results: Of patients, 77.3%, 68.4%, and 20.6% had antibiotic prophylaxis, antifungal prophylaxis, and no prophylaxis, respectively. There were totally 15 deaths—13 with antibiotic prophylaxis and 10 with antifungal prophylaxis. CRP, PCT, and immediate outcome measures of NF did not show significant differences between those with and without antimicrobial prophylaxis. Although between-group differences showed no statistical significance, higher median fever duration, CRP and PTC values, and higher proportions of NF requiring modification of antibiotics were found more frequently in those with antimicrobial prophylaxis than in those without. Conclusion: The benefits of using antimicrobial prophylaxis were less supported. Enhancing diagnostic laboratory and medical complication surveillance and periodic evaluation of institutional data during post-chemotherapy neutropenia and NF in relation to antimicrobial prophylaxis is promising in providing insights to redefine the risk–benefit accounts of using prophylaxis. |
Keywords: | Antibiotic or antifungal prophylaxis C-reactive protein Leukemia Post-chemotherapy neutropenic fever Procalcitonin Risk–benefit of prophylaxis |
Publisher: | Springer | Journal: | Supportive care in cancer | ISSN: | 0941-4355 | EISSN: | 1433-7339 | DOI: | 10.1007/s00520-021-06325-3 | Rights: | © 2021 THE AUTHORS. Published by Elsevier BV on behalf of Faculty of Engineering, Ain Shams University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). The following publication Chan, C. W., Molassiotis, A., & Lee, H. K. K. (2021). Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia: Comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice. Supportive Care in Cancer, 29(12), 7515-7523 is available at https://doi.org/10.1007/s00520-021-06325-3 |
| Appears in Collections: | Journal/Magazine Article |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Chan_Antimicrobial_Post_Chemotherapy.pdf | 567.65 kB | Adobe PDF | View/Open |
Access
View full-text via PolyU eLinks 
Page views
27
Last Week
2
2
Last month
Citations as of May 28, 2023
Downloads
3
Citations as of May 28, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.